RECENT POSTS
Sunday, October 21, 2018
Charting Netflix Growth in Three Ways

Wednesday, October 17, 2018
Interesting Data on Interest Income

Thursday, October 11, 2018
The Decline of Sears in Three Charts

Wednesday, October 3, 2018
Buying Revenue At Any Cost...The (Not So) New Strategy For IPOs?

Sunday, September 30, 2018
Campbell Soup Gets Squeezed

Wednesday, September 26, 2018
Exchange Rate Effects on Cash

Monday, September 24, 2018
The Missing Unremitted Foreign Earnings

Tuesday, September 18, 2018
Thoughts on Structured Data

Sunday, September 16, 2018
Calcbench Goes to the Movies

Wednesday, September 12, 2018
The First-Ever Calcbench Webinar

Friday, August 31, 2018
Q&A: Ahmet Kurt and Researching Financial Data Quality

Friday, August 17, 2018
Leasing Costs and the Income Statement

Wednesday, August 15, 2018
Costs of Revenue, SG&A: Q2 Update

Tuesday, August 14, 2018
Who is affected by Turkey?

Wednesday, August 8, 2018
Lease Accounting and Return on Assets

Thursday, August 2, 2018
Latest Look at Leasing Liabilities

Thursday, July 26, 2018
Bargain Hunting in Calcbench

Wednesday, July 25, 2018
Chicken Soup for the Analyst’s Soul

Thursday, July 19, 2018
Calcbench Report: Share Repurchase Programs

Tuesday, July 17, 2018
Free Cash Flow, Big Filers and Small

Archive  |  Search:
R&D Big Spenders in 2017
Monday, March 12, 2018

Now that a large majority of S&P 500 firms have filed their 2017 annual reports, Calcbench will occasionally look at some specific line item to see how Corporate America is spending its money.

First up: research and development costs.

Among the 446 companies that have submitted their 2017 reports already, that group spent a collective $228.2 billion on R&D last year — up 5.2 percent from the $216.9 billion that the S&P 500 spent in 2016. That $228.2 billion is 2.26 percent of total revenue for 2017, which was $10.12 trillion.

But watch out! The 2.26 percent is deceptive, because not all S&P 500 companies report R&D costs. Only 172 firms in our sample have reported R&D, and they collectively had only $3.63 trillion in revenue.

When you calculate the $228.2 billion over that smaller group, the portion of revenue devoted to R&D spending among those S&P 500 companies that report any R&D at all jumps to 6.3 percent. That’s the highest percentage we’ve seen in five years. Yay science! (See Fig. 1, below.)

So who are the biggest spenders?

First we ranked companies by total dollars spent on R&D. Don’t die of shock here, but Google topped the list (as it did in 2016, too). Four of the top 10 were tech firms, and five were pharmaceutical firms. Only Ford snuck into the list from an old school manufacturing sector, so we look forward to a flying car or something in 2019. (See Fig. 2, below.)

Next we ranked companies by percentage of revenue spent on R&D. Seven of the top 10 were pharmaceutical firms of some kind, and that’s no surprise either; many pharma and life science firms spend every penny they can find on R&D for years, until that one blockbuster drug gets approved and they start making real profits. (See Fig. 3, below.)

We should add the caveat that several large filers in the S&P 500 have yet to file their 2017 reports. Most notable is Walmart, whose revenue and R&D numbers could alter the averages for the whole group a bit, although not to a material degree.

Calcbench subscribers, meanwhile, can take this information and use it to ask better questions about the companies you follow. For example, you could calculate the average R&D spending for specific companies you follow and then quickly see what their peers spend for R&D. Then you’re well positioned to lob a few tough questions, if necessary, on that next earnings call.


FREE Calcbench Premium
Two Week Trial

Research Financial & Accounting Data Like Never Before. More features and try our Excel add-in. Sign up now to try the Premium Suite.